Prognostic Role of Inflammatory Biomarkers in Gastrointestinal Neuroendocrine Neoplasms: A Cross‐Sectional Study

Our findings suggest that NLR may serve as an independent and accessible prognostic marker in g-NENs, potentially offering a cost-effective tool to support clinical decision-making. The combined assessment of inflammatory biomarkers and histopathological parameters could improve prognostic accuracy and help guide personalized management strategies in patients with g-NENs. Nevertheless, these observations should be interpreted with caution due to the retrospective, single-center design and limited sample size. Future large-scale, prospective studies are warranted to confirm and expand upon these results.